Jardiance (empagliflozin) is an oral antidiabetic medication classified as a Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2I). It is used to manage blood sugar levels in adults with type 2 diabetes and to reduce the risk of cardiovascular death in patients with heart failure.
congrats on reading the definition of Jardiance. now let's actually learn it.
Jardiance works by inhibiting SGLT2 proteins in the kidneys, leading to increased glucose excretion through urine.
Common side effects include urinary tract infections and increased urination.
It has been shown to reduce the risk of cardiovascular death in patients with established heart disease.
Jardiance is contraindicated in individuals with severe renal impairment or end-stage renal disease.
The typical starting dose for Jardiance is 10 mg once daily, taken in the morning.
Review Questions
How does Jardiance help control blood sugar levels?
What are common side effects associated with Jardiance?
In what patient population has Jardiance shown a reduction in cardiovascular death?
Related terms
Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is): A class of medications that lower blood sugar by causing the kidneys to remove glucose from the bloodstream through urine.